These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36062389)

  • 1. Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data.
    Labriffe M; Woillard JB; Gwinner W; Braesen JH; Anglicheau D; Rabant M; Koshy P; Naesens M; Marquet P
    Am J Transplant; 2022 Dec; 22(12):2821-2833. PubMed ID: 36062389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications.
    Schinstock CA; Sapir-Pichhadze R; Naesens M; Batal I; Bagnasco S; Bow L; Campbell P; Clahsen-van Groningen MC; Cooper M; Cozzi E; Dadhania D; Diekmann F; Budde K; Lower F; Orandi BJ; Rowshani AT; Cornell L; Kraus E
    Am J Transplant; 2019 Jan; 19(1):123-131. PubMed ID: 29935060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
    Haas M; Loupy A; Lefaucheur C; Roufosse C; Glotz D; Seron D; Nankivell BJ; Halloran PF; Colvin RB; Akalin E; Alachkar N; Bagnasco S; Bouatou Y; Becker JU; Cornell LD; Duong van Huyen JP; Gibson IW; Kraus ES; Mannon RB; Naesens M; Nickeleit V; Nickerson P; Segev DL; Singh HK; Stegall M; Randhawa P; Racusen L; Solez K; Mengel M
    Am J Transplant; 2018 Feb; 18(2):293-307. PubMed ID: 29243394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
    Loupy A; Haas M; Solez K; Racusen L; Glotz D; Seron D; Nankivell BJ; Colvin RB; Afrouzian M; Akalin E; Alachkar N; Bagnasco S; Becker JU; Cornell L; Drachenberg C; Dragun D; de Kort H; Gibson IW; Kraus ES; Lefaucheur C; Legendre C; Liapis H; Muthukumar T; Nickeleit V; Orandi B; Park W; Rabant M; Randhawa P; Reed EF; Roufosse C; Seshan SV; Sis B; Singh HK; Schinstock C; Tambur A; Zeevi A; Mengel M
    Am J Transplant; 2017 Jan; 17(1):28-41. PubMed ID: 27862883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of paediatric kidney transplant recipients using the updated 2013/2017 Banff histopathological classification for antibody-mediated rejection.
    Preka E; Sekar T; Lopez Garcia SC; Shaw O; Kessaris N; Mamode N; Stojanovic J; Sebire NJ; Kim JJ; Marks SD
    Pediatr Nephrol; 2021 Aug; 36(8):2575-2585. PubMed ID: 34143297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiers.
    Reeve J; Böhmig GA; Eskandary F; Einecke G; Gupta G; Madill-Thomsen K; Mackova M; Halloran PF;
    Am J Transplant; 2019 Oct; 19(10):2719-2731. PubMed ID: 30868758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation.
    Callemeyn J; Ameye H; Lerut E; Senev A; Coemans M; Van Loon E; Sprangers B; Van Sandt V; Rabeyrin M; Dubois V; Thaunat O; Kuypers D; Emonds MP; Naesens M
    Am J Transplant; 2021 Jul; 21(7):2413-2423. PubMed ID: 33382185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
    Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
    Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Decentralized Kidney Transplant Biopsy Classifier for Transplant Rejection Developed Using Genes of the Banff-Human Organ Transplant Panel.
    van Baardwijk M; Cristoferi I; Ju J; Varol H; Minnee RC; Reinders MEJ; Li Y; Stubbs AP; Clahsen-van Groningen MC
    Front Immunol; 2022; 13():841519. PubMed ID: 35619722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction.
    Gimeno J; Redondo D; Pérez-Sáez MJ; Naranjo-Hans D; Pascual J; Crespo M
    Nephrol Dial Transplant; 2016 Nov; 31(11):1938-1946. PubMed ID: 27312147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort study.
    Schinstock CA; Askar M; Bagnasco SM; Batal I; Bow L; Budde K; Campbell P; Carroll R; Clahsen-van Groningen MC; Cooper M; Cornell LD; Cozzi E; Dadhania D; Diekmann F; Hesselink DA; Jackson AM; Kikic Z; Lower F; Naesens M; Roelofs JJ; Sapir-Pichhadze R; Kraus ES
    Transpl Int; 2021 Mar; 34(3):488-498. PubMed ID: 33423340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between pathologic lesions of active and chronic antibody-mediated rejection in renal allografts.
    Haas M
    Am J Transplant; 2018 Dec; 18(12):2849-2856. PubMed ID: 30133953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell mediated rejection revisited: Past, current, and future directions.
    Hara S
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():45-51. PubMed ID: 29968416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection.
    Loupy A; Haas M; Roufosse C; Naesens M; Adam B; Afrouzian M; Akalin E; Alachkar N; Bagnasco S; Becker JU; Cornell LD; Clahsen-van Groningen MC; Demetris AJ; Dragun D; Duong van Huyen JP; Farris AB; Fogo AB; Gibson IW; Glotz D; Gueguen J; Kikic Z; Kozakowski N; Kraus E; Lefaucheur C; Liapis H; Mannon RB; Montgomery RA; Nankivell BJ; Nickeleit V; Nickerson P; Rabant M; Racusen L; Randhawa P; Robin B; Rosales IA; Sapir-Pichhadze R; Schinstock CA; Seron D; Singh HK; Smith RN; Stegall MD; Zeevi A; Solez K; Colvin RB; Mengel M
    Am J Transplant; 2020 Sep; 20(9):2318-2331. PubMed ID: 32463180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations.
    Haas M
    Am J Transplant; 2016 May; 16(5):1352-7. PubMed ID: 26696524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials - a retrospective study.
    Smith B; Cornell LD; Smith M; Cortese C; Geiger X; Alexander MP; Ryan M; Park W; Morales Alvarez MC; Schinstock C; Kremers W; Stegall M
    Transpl Int; 2019 Feb; 32(2):173-183. PubMed ID: 30179275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and pathological significance of borderline T cell-mediated rejection.
    Nankivell BJ; Agrawal N; Sharma A; Taverniti A; P'Ng CH; Shingde M; Wong G; Chapman JR
    Am J Transplant; 2019 May; 19(5):1452-1463. PubMed ID: 30501008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Organ Transplant; 2014 Jun; 19(3):315-22. PubMed ID: 24811440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.